Open access · OA
via OpenAlex
Cardiac fibrosis in the ageing heart: Contributors and mechanisms
Lu Lu, Jingbin Guo, Yue Hua, Kevin W. Huang, Ruth Magaye, Jake Cornell, Darren J. Kelly, Christopher Michael Reid, Danny Liew, Yingchun Zhou, Aihua Chen, Wei Lie Xiao, Qiang Fu, Bing Hui Wang
Clinical and Experimental Pharmacology and Physiology · 2017 · ▲ 94 citations
Abstract
Cardiac fibrosis refers to an excessive deposition of extracellular matrix (ECM) in cardiac tissue. Fibrotic tissue is stiffer and less compliant, resulting in subsequent cardiac dysfunction and heart failure. Cardiac fibrosis in the ageing heart may involve activation of fibrogenic signalling and inhibition of anti-fibrotic signalling, leading to an imbalance of ECM turnover. Excessive accumulation of ECM such as collagen in older patients contributes to progressive ventricular dysfunction. Overexpression of collagen is derived from various sources, including higher levels of fibrogenic growth factors, proliferation of fibroblasts and cellular transdifferentiation. These may be triggered by factors, such as oxidative stress, inflammation, hypertension, cellular senescence(definition) and cell death, contributing to age-related fibrotic cardiac remodelling. In this review, we will discuss the fibrogenic contributors in age-related cardiac fibrosis, and the potential mechanisms by which fibrogenic processes can be interrupted for therapeutic intent.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/1440-1681.12753
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Lu, L., Guo, J., Hua, Y., Huang, K.W., Magaye, R., Cornell, J., Kelly, D.J., Reid, C.M., Liew, D., Zhou, Y., Chen, A., Xiao, W.L., Fu, Q., & Wang, B.H. (2017). Cardiac fibrosis in the ageing heart: Contributors and mechanisms. <em>Clinical and Experimental Pharmacology and Physiology</em>. https://doi.org/10.1111/1440-1681.12753
Vancouver
Lu L, Guo J, Hua Y, Huang KW, Magaye R, Cornell J, et al. Cardiac fibrosis in the ageing heart: Contributors and mechanisms. Clinical and Experimental Pharmacology and Physiology. 2017. doi:10.1111/1440-1681.12753.
BibTeX
@article{lu2017Cardia,
title = {Cardiac fibrosis in the ageing heart: Contributors and mechanisms},
author = {Lu Lu and Jingbin Guo and Yue Hua and Kevin W. Huang and Ruth Magaye and Jake Cornell and Darren J. Kelly and Christopher Michael Reid and Danny Liew and Yingchun Zhou and Aihua Chen and Wei Lie Xiao and Qiang Fu and Bing Hui Wang},
journal = {Clinical and Experimental Pharmacology and Physiology},
year = {2017},
doi = {10.1111/1440-1681.12753},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Signal Transduction and Targeted Therapy 2026
Open access · CC-BY
Cardiovascular ageing: hallmarks, signaling pathways, diseases and therapeutic targets
Signal transduction and targeted therapy 2026
Open access · OA
Cardiovascular ageing: hallmarks, signaling pathways, diseases and therapeutic targets.
Journal of Molecular and Cellular Cardiology 2015
Open access · CC-BY
Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling
Nutrients 2018
Open access · CC-BY
Protective Role of Polyphenols against Vascular Inflammation, Aging and Cardiovascular Disease
Frontiers in immunology 2026
Open access · OA
Cellular senescence in Crohn's disease: a double-edged sword in intestinal fibrosis.
Preprints.org 2026
Preprint · CC-BY